Clinical trial
Diagnosis of Tuberculous Meningitis by a Secretory Antigenic Target 6 (ESAT-6) in CSF
NCT01371916 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnosis of Tuberculous Meningitis by a Secretory Antigenic Target 6 (ESAT-6) in CSF
- Lead sponsor
- Xijing Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- January 31, 2014
- Enrollment
- 316 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tuberculous meningitis